Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 33%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

CME Group has demonstrated robust growth, as evidenced by a record revenue of $1.7 billion, reflecting a 10% year-over-year increase, driven by strong demand in Clearing & Transaction and Market Data revenue sectors. The company has also shown exceptional performance in attracting new retail traders, adding over 90,000 new accounts, which marks a 56% year-over-year increase and indicates sustained interest in futures trading amidst favorable market conditions. Additionally, CME's strategic expansions, including its stake in S&P Dow Jones Indices and the acquisition of NEX, position it favorably for continued growth in global benchmarks and enhanced capital efficiency offerings, particularly in a rising rate environment.

Bears say

CME Group faces significant risks due to a potential decline in open interest (OI), which could lead to deteriorating market sentiment and negative financial conditions, adversely affecting its stock performance. Regulatory uncertainties, such as increased margin requirements and restrictions on trading practices, may further reduce trading volumes, which are crucial for the company's revenue generation. Additionally, the company's reliance on market volatility and elevated trading volumes, influenced by geopolitical tensions and economic uncertainties, poses a fundamental threat to its financial outlook, suggesting a negative trajectory for future earnings.

CME Group (CME) has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 12 analysts, CME Group (CME) has a Hold consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $284.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $284.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.